Singapore markets closed

Willow Biosciences Inc. (WLLW.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.08500.0000 (0.00%)
At close: 02:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-13,029
-13,029
-14,814
-6,140
-33,946
-
Depreciation & amortisation
1,831
1,831
2,646
3,192
3,182
-
Deferred income taxes
-15
-15
0
-
0
-1,580
Stock-based compensation
420
420
1,461
1,703
951
-
Change in working capital
-207
-207
129
-316
-211
-
Other working capital
-11,539
-11,539
-14,544
-19,993
-13,777
-
Other non-cash items
84
84
473
27
40
-
Net cash provided by operating activities
-10,920
-10,920
-13,862
-18,227
-12,780
-
Cash flows from investing activities
Investments in property, plant and equipment
-619
-619
-682
-1,766
-997
-
Purchases of investments
-
-
-4,020
0
-
-
Sales/maturities of investments
4,000
4,000
-
-
-
-
Other investing activities
77
77
26
-27
-5
-
Net cash used for investing activities
3,465
3,465
-4,553
-1,674
-837
-
Cash flows from financing activities
Debt repayment
-1,012
-1,012
-723
-637
-651
-
Common stock issued
-
-
0
26,730
10,516
27,377
Other financing activities
-106
-106
-
-2
25
-111
Net cash used provided by (used for) financing activities
-318
-318
-723
34,126
9,890
-
Net change in cash
-7,773
-7,773
-19,138
14,225
-3,727
-
Cash at beginning of period
11,007
11,007
30,119
15,895
19,644
-
Cash at end of period
3,145
3,145
11,007
30,119
15,895
-
Free cash flow
Operating cash flow
-10,920
-10,920
-13,862
-18,227
-12,780
-
Capital expenditure
-619
-619
-682
-1,766
-997
-
Free cash flow
-11,539
-11,539
-14,544
-19,993
-13,777
-